Allergan (NYSE:AGN) Decides to Acquire SkinMedica in a $350 Million Deal – NVS, JNJ, VRX

Allergan, Inc (NYSE:AGN) reported that it decided to acquire SkinMedica Inc’s topical-aesthetics skin-care unit for $350 million to boost its presence in the skin-care market.

The agreement comprises an additional $25 million in payments, dependent on the SkinMedica products reaching certain sales targets.

Chief Executive officer of Allergan David E.I. Pyott reported that the SkinMedica purchases should complement its present businesses, comprising Botox.

Allergan previous month announced a slight drop in its Q3 earnings and reported that it was looking for a sale of its weight-loss-surgery business, Lap-Band.

Shifting readers focus to broader market, let’s consider market performance of other stocks that significantly affect same sector. Novartis AG (ADR) (NYSE:NVS) surged +0.05% to settle at $59.00, Johnson & Johnson (NYSE:JNJ) moved up +0.17% to end at $69.19 while Valeant Pharmaceuticals Intl Inc (NYSE:VRX) jumped +3.21% to finish on Friday at $55.03.

Allergan, Inc. (NYSE:AGN) last session volume of 1.83 million shares was higher than its average volume of 1.58 million shares. The stock after opening at $87.73 hit high price of $89.32 and then closed at $88.71 by scoring +0.86%.

AGN generated revenue of 5.70 billion in the following twelve months and earned $1.05 billion. The Company showed a positive 18.55% in the net profit margin and as well as in its operating margin which remained 27.32%. Company’s annual sales growth for the past five year was 12.09%.

The AGN past twelve months price to sales ratio was 4.79 and price to cash ratio remained 9.30. As far as the returns are concern, the AGN return on equity was recorded as 19.75% and increased 14.03% return on investment while its return on asset stayed at 12.37%.

The stock showed weekly downbeat performance of -1.91% which was maintained for the month at -5.76%. Likewise the negative performance for the quarter was recorded as 2.63% and for the year was 6.04% while the YTD performance remained at 1.28%.

DO NOT TRADE ANY STOCK WITHOUT LEVEL 2 STOCK QUOTES! delivers it's user with the most in-depth Level 2 Quotation System available on the Planet! NO Downloads, NO Widgets, NO Plugins required! Stay on TOP of your trades with! CLICK HERE TO START YOUR FREE 30-DAY TRIAL

This entry was posted in Latest Headlines, Services and tagged , , , , , , , , , , , . Bookmark the permalink.